In 158 adult smokers, a Bayesian analysis gave a 92.7% probability that neuroaffective profile modified varenicline vs NRT efficacy: end-of-treatment abstinence was 47% vs 11% in sign-trackers and 29% vs 17% in goal-trackers.
RCTn = 158
Versace et al. Personalizing smoking cessation pharmacotherapy using neuroaffective reactivity profiles: A randomized controlled trial